BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2716439)

  • 1. Psychophysiological research in psychiatry and neuropsychopharmacology. II. The investigation of antihypoxidotic/nootropic drugs (tenilsetam and co-dergocrine-mesylate) in elderlies with the Viennese Psychophysiological Test-System (VPTS).
    Saletu B; Semlitsch HV; Anderer P; Resch F; Presslich O; Schuster P
    Methods Find Exp Clin Pharmacol; 1989 Jan; 11(1):43-55. PubMed ID: 2716439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies.
    Saletu B; Grünberger J; Anderer R
    Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):510-24. PubMed ID: 2086492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychophysiological research in psychiatry and neuropsychopharmacology. I. Methodological aspects of the Viennese Psychophysiological Test-System (VPTS).
    Semlitsch HV; Anderer P; Saletu B; Resch F; Presslich O; Schuster P
    Methods Find Exp Clin Pharmacol; 1989 Jan; 11(1):25-41. PubMed ID: 2716438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairment.
    Semlitsch HV; Anderer P; Saletu B; Hochmayer I
    Neuropsychobiology; 1990-1991; 24(1):49-56. PubMed ID: 2132641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment.
    Semlitsch HV; Anderer P; Saletu B; Binder GA; Decker KA
    Pharmacopsychiatry; 1995 Jul; 28(4):134-42. PubMed ID: 7491367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term study with co-dergocrine mesylate (Hydergine) in healthy pensioners. Results after 3 years.
    Köberle S; Spiegel R
    Gerontology; 1984; 30 Suppl 1():3-52. PubMed ID: 6489764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects.
    Semlitsch HV; Anderer P; Saletu B
    Eur J Clin Pharmacol; 1995; 49(3):183-91. PubMed ID: 8665994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
    Nobuhara K
    Seishin Shinkeigaku Zasshi; 1993; 95(5):392-416. PubMed ID: 8356168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Psychopharmacology (Berl); 1992; 109(1-2):30-40. PubMed ID: 1365669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies.
    Saletu B; Schulz H; Herrmann WM; Anderer P; Shrotriya RC; Vanbrabant E
    Pharmacopsychiatry; 1994 Sep; 27(5):189-97. PubMed ID: 7838889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized placebo-controlled double-blind cross-over study on antihypoxidotic effects of piracetam using psychophysiological measures in healthy volunteers.
    Schaffler K; Klausnitzer W
    Arzneimittelforschung; 1988 Feb; 38(2):288-91. PubMed ID: 3370078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypoxidotic and nootropic drugs: proof of their encephalotropic and pharmacodynamic properties by quantitative EEG investigations.
    Saletu B; Grünberger J
    Prog Neuropsychopharmacol; 1980; 4(4-5):469-89. PubMed ID: 7012879
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
    Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
    Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Wittek R
    Arch Gerontol Geriatr; 1984 Jul; 3(2):127-46. PubMed ID: 6476974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):12-27. PubMed ID: 2883677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):362-73. PubMed ID: 3525428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flunitrazepam-induced changes in neurophysiological, behavioural, and subjective measures used to assess sedation.
    Lucchesi LM; Pompéia S; Manzano GM; Kohn AF; Galduroz JC; Bueno OF; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):525-33. PubMed ID: 12691789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.